Roivant Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ROIV and other ETFs, options, and stocks.

About ROIV

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses.

CEO

Matthew Gline

CEOMatthew Gline

Employees

904

Employees904

Headquarters

London, Greater London

HeadquartersLondon, Greater London

Founded

2014

Founded2014

Employees

904

Employees904

ROIV Key Statistics

Market cap

8.78B

Market cap8.78B

Price-Earnings ratio

2.09

Price-Earnings ratio2.09

Dividend yield

—

Dividend yield—

Average volume

4.51M

Average volume4.51M

High today

$11.05

High today$11.05

Low today

$10.88

Low today$10.88

Open price

$10.93

Open price$10.93

Volume

861.57K

Volume861.57K

52 Week high

$13.24

52 Week high$13.24

52 Week low

$8.06

52 Week low$8.06

Analyst ratings

92%

of 12 ratings

Buy

91.7%

Hold

8.3%

Sell